Literature DB >> 8652024

Intravenous gamma-globulin treatment in a patient with subacute sclerosing panencephalitis.

Y K Gürer1, S Kükner, B Sarica.   

Abstract

A 10-year-old boy with subacute sclerosing panencephalitis was treated with intravenous gamma-globulin and inosiplex and followed for 18 months. Clinical improvement, demonstrated by decreasing scores on the Neurologic Disability Index, was observed. There were no side effects. We recommend intravenous immune globulin as an alternative therapy in the treatment of subacute sclerosing panencephalitis.

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8652024     DOI： 10.1016/0887-8994(95)00257-x

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN： 0887-8994            Impact factor:   3.372


  5 in total

Review 1.  Subacute sclerosing panencephalitis.

Authors:  R K Garg
Journal:  Postgrad Med J       Date:  2002-02       Impact factor: 2.401

2.  Subacute sclerosing panencephalitis : diagnosis and drug treatment options.

Authors:  B Anlar
Journal:  CNS Drugs       Date:  1997-02       Impact factor: 5.749

Review 3.  Subacute sclerosing panencephalitis: results of the Canadian Paediatric Surveillance Program and review of the literature.

Authors:  Craig Campbell; Simon Levin; Peter Humphreys; Wikke Walop; Renee Brannan
Journal:  BMC Pediatr       Date:  2005-12-15       Impact factor: 2.125

Review 4.  Options in the Treatment of Subacute Sclerosing Panencephalitis: Implications for Low Resource Areas.

Authors:  Pauline Samia; Katherine Oyieke; Dorcas Tunje; Anaita Udwadia-Hegde; Kristen Feemster; Ibrahim Oncel; Banu Anlar
Journal:  Curr Treat Options Neurol       Date:  2022-03-19       Impact factor: 3.972

5.  Atypical clinical course subacute sclerosing panencephalitis presenting as acute Encephalitis.

Authors:  Mustafa Komur; Ali E Arslankoylu; Cetin Okuyaz; Necdet Kuyucu
Journal:  J Pediatr Neurosci       Date:  2012-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.